Wednesday, 15 March 2017

New UK drug cost rules leave companies fuming

LONDON (Reuters) - British drugmakers on Wednesday accused Theresa May's Conservative government of breaking a manifesto commitment to improve access to new medicines, following approval of new cost rules that take effect on April 1.


No comments:

Post a Comment